Icon plc is a leading global ESG-compliant late-stage contract research organization specializing in providing pharmaceutical, biotechnology, and medical-device companies with top-notch drug development and clinical trial services. Based in Ireland, the company also offers additional services like laboratory and imaging capabilities. With a low-risk ESG score of 15.6, Icon plc is a trusted partner for firms looking for reliable and efficient clinical research solutions.